Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats

Neuroscience

Volumn 92, Issue 1, 1999, Pages 113-121

  Bakshi, V P ^a   Geyer, M A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amygdala; Hippocampus; NMDA; Phencyclidine; Schizophrenia; Startle

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; CLOZAPINE; DIZOCILPINE; OLANZAPINE; PHENCYCLIDINE; PRAZOSIN; QUETIAPINE;

ADRENERGIC SYSTEM; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; MALE; NERVE PROJECTION; NEUROMODULATION; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORIMOTOR CORTEX; STARTLE REFLEX;

ADRENERGIC ALPHA-ANTAGONISTS; AMYGDALA; ANIMALS; DIBENZOTHIAZEPINES; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; INJECTIONS; MALE; MOTOR CORTEX; NEURAL INHIBITION; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA; SOMATOSENSORY CORTEX; STARTLE REACTION;

EID: 0033031614     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00752-0     Document Type: Article

References (50)

1. Allen R.M., Young S.J. Phencyclidine-induced psychosis. Am. J. Psychiat. 135:1978;1081-1084.
2. Bakshi V.P., Geyer M.A. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology. 122:1995;198-201.
3. Bakshi V.P., Geyer M.A. Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist, dizocilpine. J. Neurosci. 18:1998;8394-8401.
4. Bakshi V.P., Geyer M.A. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist. J. Pharmac. exp. Ther. 283:1997;666-674.
5. Bakshi V.P., Geyer M.A., Taaid N., Swerdlow N.R. A comparison of the effects of amphetamine, strychnine and caffeine on prepulse inhibition and latent inhibition. Behav. Pharmac. 6:1995;801-809.
6. Bakshi V.P., Swerdlow N.R., Geyer M.A. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J. Pharmac. exp. Ther. 271:1994;787-794.
7. Bolino F., Di Michele V., Di Cicco L., Manna V., Daneluzzo E., Cassachia M. Sensorimotor gating and habituation evoked by electrocutaneous stimulation in schizophrenia. Biol. Psychiat. 36:1994;670-679.
8. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia: human and animal model studies. Archs gen. Psychiat. 47:1990;181-188.
9. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Archs gen. Psychiat. 49:1992;206-215.
10. Braff D.L., Stone C., Callaway E., Geyer M.A., Glick I.D., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
11. Breier A., Wolkowitz O.M., Roy A., Potter W.Z., Pickar D. Plasma norepinephrine in chronic schizophrenia. Am. J. Psychiat. 147:1990;1467-1470.
12. Bymaster F.P., Calligaro D.O., Falcone J.F., Marsh R.D., Moore N.A., Tye N.C., Seeman P., Wong D.T. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology. 14:1996;87-96.
13. Cadenhead K.S., Geyer M.A., Braff D.L. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am. J. Psychiat. 150:1993;1862-1867.
14. Carasso B.S., Bakshi V.P., Geyer M.A. Disruption in prepulse inhibition after alpha-1 adrenoceptor stimulation in rats. Neuropharmacology. 37:1998;401-404.
15. Coward D.M. General pharmacology of clozapine. Br. J. Psychiat. 160(Suppl. 17):1992;5-11.
16. Davis M., Gendelman D.S., Tischler M.D., Gendelman P.M. A primary acoustic startle circuit: lesion and stimulation studies. J. Neurosci. 2:1982;791-805.
17. Geyer M.A., Swerdlow N.R., Mansbach R.S., Braff D.L. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res. Bull. 25:1990;485-498.
18. Grillon C., Ameli R., Charney D.S., Krystal J., Braff D.L. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol. Psychiat. 32:1992;939-943.
19. Hamm A., Weike A., Bauer U., Vaitl D., Gallhofer B. Prepulse inhibition in medicated and unmedicated schizophrenics. Psychophysiology. 32(Suppl. 1):1995;S65.
20. Hoffman D.C., Donovan H., Cassella J.V. The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801. Psychopharmacology. 111:1993;339-344.
21. Hoffman H.S., Ison J.R. Reflex modification in the domain of startle: I. Some emprical findings and their implications for how the nervous system processes sensory input. Psychol. Rev. 87:1980;175-189.
22. Hondo H., Yonezawa Y., Nakahara T., Nakamura K., Hirano M., Uchimura H., Tashiro N. Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study. Brain Res. 633:1994;337-342.
23. Hori T., Suzuki T., Baba A., Abe S., Yamamoto T., Moroji T., Shiraishi H. Effects of phencyclidine metabolites on serotonin uptake in rat brain. Neurosci. Lett. 209:1996;153-156.
24. Hutson P.H., Hogg J.E. Effects of and interactions between antagonists for different sites on the NMDA receptor complex on hippocampal and striatal acetylcholine efflux in vivo. Eur. J. Pharmac. 295:1996;45-52.
25. Ison J.R., Hoffman H.S. Reflex modification in the domain of startle: II. The anomalous history of a robust and ubiquitous phenomenon. Psychol. Bull. 94:1983;3-17.
26. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiat. 148:1991;1301-1308.
27. Karper L.P., Grillon C., Morissey K., Abi-Saab D., Morgan C.A., Charney D.S., Krystal J.H. The effect of ketamine on the acoustic startle response. Soc. Neurosci. Abstr. 20:1994;482.
28. Keith V.A., Mansbach R.S., Geyer M.A. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol. Psychiat. 30:1991;557-566.
29. Kodsi M.H., Swerdlow N.R. Quinolinic acid lesions of the ventral striatum reduce sensorimotor gating of acoustic startle in rats. Brain Res. 643:1994;59-65.
30. Kodsi M.H., Swerdlow N.R. Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry. Behav. Neurosci. 109:1995;912-928.
31. Kodsi M.H., Swerdlow N.R. Regulation of prepulse inhibition by ventral pallidal projections. Brain Res. Bull. 43:1997;219-228.
32. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B., Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Archs gen. Psychiat. 51:1994;199-214.
33. Mansbach R.S., Geyer M.A. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology. 2:1989;299-308.
34. Mansbach R.S., Geyer M.A. Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine. Psychopharmacology. 105:1991;162-168.
35. Mansbach R.S., Geyer M.A., Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology. 94:1988;507-514.
36. Mathe J.M., Nomikos G.G., Hildebrand B.E., Hertel P., Svensson T.H. Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens. Eur. J. Pharmac. 309:1996;1-11.
37. McGhie A., Chapman J. Disorders of attention and perception in early schizophrenia. Br. J. Med. Psychol. 34:1961;103-116.
38. Moore N.A., Calligaro D.O., Wong D.T., Bymaster F., Tye N.C. The pharmacology of olanzapine and other new antipsychotic agents. Curr. Opin. invest. Drugs. 2:1993;281-293.
39. Nuechterlein K.H., Dawson M.E. Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr. Bull. 10:1985;160-203.
40. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic, Sydney.
41. Pellegrino L. J., Pellegrino A. S. and Cushman A. J. (1979) A Stereotaxic Atlas of the Rat Brain. Plenum, New York.
42. Pieribone V.A., Nicholas A.P., Dagerlind A., Hokfelt T. Distribution of α1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes. J. Neurosci. 14:1994;4252-4268.
43. Robertson D. and Curatolo P. W. (1984) The cardiovascular effects of caffeine. In Caffeine, Perspectives from Current Research (ed. Dews P. B.), pp. 77-85. Springer, New York.
44. 3H]noradrenaline uptake in brain synaptosomes and adrenal chromaffin cells. Br. J. Pharmac. 103:1991;1917-1922.
45. Saller C.F., Salama A.I. Seroquel: biochemical profile of a potential atypical antipsychotic. Psychopharmacology. 112:1993;285-292.
46. Svensson T.H., Mathe J.M., Andersson J.L., Nomikos G.G., Hildebrand B.E., Marcus M. Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and α1-adrenoceptor antagonism. J. clin. Psychopharmac. 15(Suppl. 1):1995;11S-18S.
47. Swerdlow N.R., Bakshi V.P., Geyer M.A. Seroquel restores sensorimotor gating in phencyclidine-treated rats. J. Pharmac. exp. Ther. 279:1996;1290-1299.
48. Swerdlow N.R., Benbow C.H., Zisook S., Geyer M.A., Braff D.L. A preliminary assessment of sensorimotor gating in patients with OCD. Biol. Psychiat. 33:1993;298-301.
49. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Archs gen. Psychiat. 51:1994;139-154.
50. Venables P.H. The effect of auditory and visual stimulation on the skin potential responses of schizophrenics. Brain. 83:1960;77-92.